Scientists have developed a promising regenerative option for people suffering from chronic neck and back pain caused by degenerative disc disease (DDD): an injectable hydrogel that could serve as a minimally invasive alternative to traditional surgery. This advanced biocompatible gel is engineered to closely replicate the nucleus pulposus—the soft, gel-like core of intervertebral discs—delivering immediate structural support while restoring lost disc height and hydration. Administered via a simple needle injection, the hydrogel fills in degraded areas, recreates a supportive microenvironment, and helps stabilize the spine without the need for open procedures. Unlike conventional treatments that primarily manage symptoms through pain relief or fusion surgery, this approach targets the underlying structural breakdown of the disc itself. Many hydrogel formulations also function as sophisticated delivery platforms, carrying stem cells, growth factors, or other bioactive agents directly to the damaged site. These components work to suppress inflammation, inhibit destructive enzymes, and promote the body's natural repair processes, potentially encouraging tissue regeneration over time. Early clinical and preclinical studies, including trials with products like HYDRAFIL (from ReGelTec) for lumbar discs, have shown encouraging results: significant reductions in pain and disability, maintained disc height, and improved function in patients followed for up to a year or more. While much of the current focus remains on lower back (lumbar) applications, similar principles are being explored for cervical (neck) degeneration in regenerative medicine research, with hydrogels showing potential to alleviate nerve compression, restore cushioning, and enhance mobility. This hydrogel-based therapy represents a meaningful step toward long-term recovery by addressing disc degeneration at its source, offering hope for reduced reliance on invasive spinal fusions and a path to preserving natural spinal movement. Ongoing trials and refinements will determine its full efficacy and applicability across different spinal regions. [Tang et al. (2026): "Cell and Hydrogel‐Integrated Therapies for Intervertebral Disc Regeneration." Discusses hydrogel scaffolds for cell delivery in IDD, with potential for cervical/lumbar applications. Published in Advanced Healthcare Materials. DOI: 10.1002/adhm.202502354]